📈👀 Top CEO Trades this Week (July 21)

This is CEO Watcher. We are tracking the trades of the CEOs with the best historic returns so we can buy their stock when they do.

This week we found:

• Three insider purchases at $THRX

• A director with 300% returns bought into an IPO

• Dustin Moskovits keeps buying Asana

👀 Top Insider Trades this Week

🥇 Foresite Capital Management - 10% Owner at $THRX (link)

They just made their second-ever purchase of $THRX after the stock fell 70% due to poor clinical trial results. Their previous purchase of $THRX was up 90% in the next 90 days and they have great 90-day returns on all 3 of their previous trades (one previous purchase of $THRX and two previous purchases of $PRDS).

* Two other directors bought this stock this week too.

Historic Returns and Win Rate

• Overall: 11% returns with a 67% win rate (2/3 trades)

• 1-year: N/A (none of their purchases are a year old yet)

• 90-day: 69% returns with a 100% win rate (3/3 trades)

Purchase Data (this week)

• Total Amount Purchased: $2,079,000

• Purchase Price: $2.97

• Current Price: $3.20 (+8%)

Rating

• Rating: 8

• Why: The stock is down 70%, the purchase is sizable, and their previous three purchases have killer 90-day returns. The things preventing this from being a 9 or 10 rating are: it’s only their 3rd largest purchase (the two larger purchases were for $2.5M and $11M) and they only have 3 previous trades which isn’t much history. Pharma companies are notoriously volatile, so this is a high-risk, high-reward trade.

🥈 Carl Gordon - Director at $THRX (link)

You’ll recognize this ticker because the #1 trade this week was also a purchase of $THRX! It’s rare that we get multiple insider purchases of the same stock AND those multiple insiders have good historic returns.

Historic Returns and Win Rate

• Overall: 8% returns with a 48% win rate (11/23 trades)

• 1-year: 26% returns with a 56% win rate (10/18 trades)

• 90-day: 12% returns with a 75% win rate (15/20 trades)

Purchase Data (this week)

• Total Amount Purchased: $1,463,790

• Purchase Price: $3.05

• Current Price: $3.20 (+5%)

Rating

• Rating: 7

• Why: His returns aren’t as great as Foresite Capital Management (the #1 trade), but his returns are still fairly good and he has much more history.

🥉 Beth Seidenberg - Director at $SGMT (link)

Beth bought some $SGMT (on behalf of her fund) during their IPO this week.

Historic Returns and Win Rate

• Overall: 101% returns with a 100% win rate (16/16 trades)

• 1-year: 317% returns with a 100% win rate (15/15 trades)

• 90-day: 23% returns with a 100% win rate (3/3 trades)

Purchase Data (this week)

• Total Amount Purchased: $750,000

• Purchase Price: $16

• Current Price: $15.78 (-1%)

Rating

• Rating: 6

• Why: You may disagree with this rating because her returns are insane, but this purchase was made as part of $SGMT’s IPO, so I believe it has less signal. It’s also one of her lowest purchase sizes ever. However, her returns are absolutely killer which may still convince you to take a chance on this one.

💰 Other Insider Trades

Dustin Moskovitz - CEO at $ASAN (link): As you know from previous emails, Dustin has been gobbling up over $1B of Asana stock over the last couple of years. He is WAY underwater on these purchases but continues to buy. The stock is up almost 100% this year, so it may finally be turning around.

Read last week’s email with more info about his purchases here